2-Methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrobromide

Catalog No.: 
ACZORW107
CAS No.: 
1881288-21-6
Molecular Formula: 
C11H14BrNO2
Molecular Weight: 
272.14
2-Methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$121.00InquiryInquiry
1g95%$281.00InquiryInquiry
5g95%$757.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrobromide
IUPAC Name2-methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrobromide
MDL No.MFCD29764131
Molecular FormulaC11H14BrNO2
Molecular Weight272.14
SMILESCN(CC1=CC=CC=C1C2)C2C(O)=O.Br
InChI KeySABJDKNFWNGJER-UHFFFAOYSA-N
Synonym2-Methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrobromide
CAS No.1881288-21-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACZORW107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAQWV601 route compound structure diagram
    ACAQWV60167123-97-1In Stock
  4. Then
  5. ACZORW107 route product structure diagram
    ACZORW1071881288-21-6
Inquiry

2. ACZORW107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZORW107 route product structure diagram
    ACZORW1071881288-21-6
Inquiry

3. ACZORW107 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZORW107 route product structure diagram
    ACZORW1071881288-21-6
Inquiry

Comments (0)